{"disease":{"id":"psoriatic-erythroderma","name":"psoriatic erythroderma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04183881","title":"A Phase 4 Clinical Study of Brodalumab","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":138,"lead_sponsor_name":"Kyowa Kirin Co., Ltd.","has_results":false},{"nct_id":"NCT05144165","title":"Systemic Treatment of Moderate-to-severe Psoriasis in Adults: Update of the French Guidelines","phase":"","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Centre of Evidence of the French Society of Dermatology","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}